Drug Delivery Insights
Growing global interest in inhaled drug delivery
Susana Ecenarro, VP R&D Qualicaps EMEA, Roquette Health & Pharma Solutions shares thoughts on the growing global interest in inhaled drug delivery.
29 Oct 2025
ReiThera: Building a future-ready CDMO
During a recent visit to ReiThera's facilities, I saw first-hand how the company is leveraging decades of vector expertise, manufacturing capabilities, and a focus on quality to help clients bring gene therapies and vaccines from concept to clinic.
15 Oct 2025
How to meet the growing demand for prefilled syringes
Christy Eatmon, global subject matter expert, steriles, Thermo Fisher Scientific explores how to meet the growing demand for prefilled syringes.
26 Jun 2025
How is V-beads technology redefining supplement delivery?
Aaron Quinn, senior manager – Europe, Vantage Nutrition highlights how V-beads technology is redefining supplement delivery.
24 Jun 2025
The future of targeted therapeutics with next-gen silica nanoparticle delivery
Nigel Theobald, CEO, N4 Pharma explores the future of targeted therapeutics with next-generation silica nanoparticle delivery.
23 Jun 2025
Q&A: Ethris and Lonza collaborate to develop spray-dried mRNA vaccines
After Lonza announced the collaboration with Ethris to develop spray-dried mRNA vaccines for Respiratory Disease Prevention, EPM spoke to Carsten Rudolph, co-founder, Ethris and Kim Shepard, director of advanced drug delivery at Lonza to learn more.
22 May 2025
Owen Mumford extends its 1ml safety syringe platform
Owen Mumford has extended its 1ml safety syringe platform by adding a companion reusable autoinjector.
3 Nov 2025
Owen Mumford launches EcoSafe safety syringe platform
Owen Mumford has extended its 1ml safety syringe platform by adding a companion reusable autoinjector.
20 Oct 2025
Owen Mumford launches EcoSafe safety syringe platform
Owen Mumford has extended its 1ml safety syringe platform by adding a companion reusable autoinjector.
16 Oct 2025
Sponsored Content
White Raven sets new standards for achieving GMP certification
Download the Playbook to learn how White Raven reached GMP certification in just 18 months.
Q&A: Syngene at CPHI Frankfurt
At CPHI Frankfurt, we sat down with Alex Del Priore, head of large molecule and interim head of small molecule at Syngene International, to discuss the company’s recent investments in peptides and antibody–drug conjugates (ADCs).
5 Dec 2025
Pinpoint accuracy: the importance of calibration in pharmaceutical measurement
Dr. Fábio A. S. Leite, subject matter expert for Pharma, Testo Saveris discusses how in the pharmaceutical sector, sensors are the frontline of medicine integrity, safeguarding sterility, maintaining quality and ultimately facilitating patient care.
4 Dec 2025
Streamlining biopharmaceutical purification with continuous chromatography
Heidi Jones, market development manager, Chromatography, Bio-Rad Laboratories discusses streamlining biopharmaceutical purification with continuous chromatography.
3 Dec 2025
Building robust and reliable paths for biologics manufacturing
Ingenza looks at building robust and reliable paths for biologics manufacturing.
28 Nov 2025
Pharmaceutical Insights + Pharmaceutical Manufacturing Insights
Integrating safety and automation
Ray Niemeyer, vice president of sales at SpaceGuard Products, discusses wire mesh guarding for robotic and automated facilities.
27 Nov 2025
Pharmaceutical Insights + Pharmaceutical Manufacturing Insights
Unifying hardware and software platforms at contract packing facilities
It would be simpler if one system controlled everything, says Bradley McEwan, business development manager at industrial packaging specialist Beckhoff UK.
26 Nov 2025
Sponsored Content
A one-stop shop for even the most challenging Monoclonal Antibodies (mAbs)
The biologics market is expanding rapidly – with a compound annual growth rate of 15% predicted until 2027. But this new generation of drugs comes with unique challenges that require an innovative approach underpinned by extensive experience.
12 Mar 2025
08:00
Sponsored Content
White Raven sets new standards for achieving GMP certification
Download the Playbook to learn how White Raven reached GMP certification in just 18 months.
Sponsored Content
A one-stop shop for even the most challenging Monoclonal Antibodies (mAbs)
The biologics market is expanding rapidly – with a compound annual growth rate of 15% predicted until 2027. But this new generation of drugs comes with unique challenges that require an innovative approach underpinned by extensive experience.
12 Mar 2025
08:00
















